Revitas, the leader in Enterprise Revenue Dynamics (ERD), today announced that a rapidly growing pharmaceutical manufacturer has gone live with its upgrade of the Revitas CARS® solution, hosted by Revitas, to process complex chargebacks and streamline revenue management processes. The company initially deployed the Revitas CARS solution to handle all revenue management activities around its products. Through this current upgrade to Revitas CARS 7.7, the manufacturer brings the latest features and functionality to its expanding organization to better support flexible and creative pricing strategies.

The pharmaceutical company chose to implement Revitas CARS in a hosted, software-as-a-service (SaaS) model, enabling maximum business agility with minimal upfront capital expenditure. By electing to upgrade its Revitas CARS solution, the company gains new functionality, including automatic data correction and chargeback rejection based on specified criteria, and the ability to manage credit and rebill submissions from distributors.

The Revitas CARS solution is a powerful and sophisticated revenue management engine that enables pharmaceutical manufacturers to optimize contract pricing and incentive payment processes and reduce the risk of revenue leakage by ensuring accurate chargeback and rebate payments. Through the solution's robust automation, pharmaceutical companies improve payment accuracy and maintain auditability for regulatory compliance. With the Revitas CARS application, rapidly growing companies can also leverage historical data about sales contract performance to design and implement creative pricing scenarios and better maximize revenue opportunities. As noted in the October 2013 Gartner report, "Nexus of Forces Adoption in Life Sciences Drives Competitive Advantage," "From a business perspective, moving data and applications to the cloud will help create a more connected and data-centric analytics capability, in which information can be leveraged across multiple systems."

"Mid-market growth companies must function at maximum efficiency in order to preserve margins in their highly competitive industry," said Mel Walker, Vice President of North American Markets at Revitas. "These companies grapple with balancing the need for powerful solutions to handle complex and elaborate pricing agreements with limited budget and IT resources. Revitas meets the needs of growing pharmaceutical companies with robust SaaS solutions like the RevitasNOW® cloud-based ERD solution suite, which provide greater visibility into current initiatives, improve business performance, and support future growth."

For more information about Revitas CARS, please visit the Revitas website.

About Revitas

Revitas, the leader in Enterprise Revenue Dynamics, delivers integrated solutions for contracts, pricing, and compliance that drive higher profitability and lower risk. Revitas empowers companies to optimize contract performance by defining, managing, and analyzing complex, multi-tier pricing incentives and enables positive proof of compliance with commercial, financial, and industry requirements. Powered by the secure, scalable, and standards-based Flex® platform, Revitas® applications speed time to market and improve visibility across B2B relationships. Hundreds of organizations across the most highly regulated and challenging industries leverage Revitas integrated solutions to save money, make money, and reduce risk. For details, visit www.revitasinc.com or http://blog.revitasinc.com/.

Revitas
Alicia Buonanno, 610-228-2096
Alicia@GregoryFCA.com